Beta adrenergic blockade on intramyocardial distribution of coronary blood flow.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002587:Cesium Isotopes; D002860:Chromium Radioisotopes; D003326:Coronary Circulation / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000098:blood supply; D006859:Hydrogen / Q000378:metabolism; D002040:Levobunolol / Q000494:pharmacology; D008863:Microspheres; D010477:Perfusion; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011868:Radioisotopes; D013326:Strontium Radioisotopes; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D002587:Cesium Isotopes; D002860:Chromium Radioisotopes; D011868:Radioisotopes; D013326:Strontium Radioisotopes; D014665:Vasodilator Agents; D006859:Hydrogen; D011433:Propranolol; D002040:Levobunolol; D011217:Practolol